Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Helicobacter pylori eradication versus standard treatment for reflux symptoms in patients with antral gastritis
IRCT201202229014N2Phase 3Unknown
- Sponsor
- Hamadan University of Medical Sciences
- Start
- May 2012
- Countries
- 1
01
Overview
Phase 3 trial of Standard Treatment-University of Calgary-acute pain-anxiety in gastroesophageal reflux disease (GERD), Helicobacter-associated gastritis and Antral Gastritis (2 arms), sponsored by Hamadan University of Medical Sciences. Status: unknown.
02
Drugs
Standard Treatment-University of Calgary-acute pain-anxiety
03
Conditions
gastroesophageal reflux disease (GERD)Helicobacter-associated gastritisAntral Gastritis
Beyond the preview
Go deeper on IRCT201202229014N2.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT201202229014N2.